Published: Wed, April 05, 2017
Science | By Boyd Webster

Getting Our Heads Around a Brain-Electrode Project

Getting Our Heads Around a Brain-Electrode Project

The Journal reported that the new startup will focus on "neural lace" technology which involves implanting tiny brain electrodes capable of uploading and downloading thoughts.

He said the "neural lace" could prevent people from becoming "house cats" to artificial intelligence. This move could improve human memory or let for fewer middlemen when interacting with computer interfaces.

"While I'm sure there will be a lot of animal and human experimentation and field trials over the next decades, it's going to be a long time before countries with liberal medical device approval processes will see widespread use of these technologies - never mind our FDA approval process in the US", observed Teich. Known for solving problems by thinking about out-of-the-box solutions, the role model for many a budding entrepreneurs has now launched a company called Neuralink Corp.

Like Musk's other firms, such as Tesla and SpaceX, Neuralink decides to come up with a working prototype to demonstrate if such an undertaking is feasible and safe before moving on to more pressing and ambitious matters at hand: actually deciding how to link human brains with AI. Merging machines and human brain could be the future of the human race as Elon Musk started to make a way to make this technology possible. As of the moment, humans only have one directional brain-computer interface that allows motor control and communication with people with brain injuries.

Musk hasn't made an official announcement but Neuralink registered in in California as a "medical research" company.

Not quite content with infiltrating garages, roofs and lunar orbit, Elon Musk has set his sights on another target - the brain.

Musk's company SpaceX recently confirmed it would be sending two "private citizens" with to the moon in 2018 - an early step in Musk's plan to save Earth's residents from eventual extinction.

He called for worldwide regulatory oversight, he said, "just to make sure we don't do something very foolish". It said it hopes to develop its initial products to treat brain diseases and illnesses like Parkinson's, depression and epilepsy.

Like this: